Next Article in Journal
Exploring Strategic Directions of Pandemic Crisis Management: A Text Analysis of World Economic Forum COVID-19 Reports
Previous Article in Journal
Roadmapping New Impact Bonds in a Post-COVID World: Insights from Case Studies in the Education Sector
Previous Article in Special Issue
Entropy Based Features Distribution for Anti-DDoS Model in SDN
Open AccessArticle

Factors Affecting Outbound Open Innovation Performance in Bio-Pharmaceutical Industry-Focus on Out-Licensing Deals

1
Graduate School of Biomedical Convergence, College of Medicine, Chungbuk National University, 1 Chungdae-ro, Seowon-gu, Cheongju 28644, Chung-cheongbuk-do, Korea
2
Korea National Industrial Convergence Center, Korea Institute of Industrial Technology, 143 Hanggaul-ro, Sangnok-gu, Ansan-si 15588, Gyeonggi-do, Korea
*
Authors to whom correspondence should be addressed.
Academic Editor: António Abreu
Sustainability 2021, 13(8), 4122; https://doi.org/10.3390/su13084122
Received: 19 February 2021 / Revised: 22 March 2021 / Accepted: 2 April 2021 / Published: 7 April 2021
(This article belongs to the Special Issue Sustainable Growth in Engineering and Technology Management)
Due to the high risk in development process, the bio-pharmaceutical industry has transformed itself into an open innovation framework in order to overcome economic risk. This study examines the relationship between outbound open innovation and financial performance in bio-pharmaceutical industry. Specifically, this study extends knowledge-based view to link the open innovation performance and licensor’s sustainability. In order to provide empirical evidence, this study uses econometric methodology with several databases including bio-pharmaceutical firms. The analysis shows firm’s desorptive capabilities have a significant effect on financial performance, confirming the application of knowledge capacity framework. The result of the study can suggest the way how the licensors can maintain the sustainability of competitiveness in bio-pharmaceutical industry. View Full-Text
Keywords: outbound open innovation; knowledge-based view (KBV); bio-pharmaceutical industry; out-licensing outbound open innovation; knowledge-based view (KBV); bio-pharmaceutical industry; out-licensing
Show Figures

Figure 1

MDPI and ACS Style

Kim, E.; Lee, I.; Kim, H.; Shin, K. Factors Affecting Outbound Open Innovation Performance in Bio-Pharmaceutical Industry-Focus on Out-Licensing Deals. Sustainability 2021, 13, 4122. https://doi.org/10.3390/su13084122

AMA Style

Kim E, Lee I, Kim H, Shin K. Factors Affecting Outbound Open Innovation Performance in Bio-Pharmaceutical Industry-Focus on Out-Licensing Deals. Sustainability. 2021; 13(8):4122. https://doi.org/10.3390/su13084122

Chicago/Turabian Style

Kim, Eungdo; Lee, InGyu; Kim, Hongbum; Shin, Kwangsoo. 2021. "Factors Affecting Outbound Open Innovation Performance in Bio-Pharmaceutical Industry-Focus on Out-Licensing Deals" Sustainability 13, no. 8: 4122. https://doi.org/10.3390/su13084122

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop